Alinsug, Jose .

HRN: 28-60-07  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/17/2026
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
02/17/2026
02/24/2026
IV
2.25G
Q6H
SEPSIS
Checking Initial Appropriateness 
02/24/2026
LEVOFLOXACIN 500MG (TAB)
02/24/2026
03/03/2026
PO
500mg
OD
Septic Encephalopathy
Checking Initial Appropriateness 
02/26/2026
RIFAXIMIN 200MG (TAB)
02/26/2026
03/05/2026
PO
2tabs
BID
Hepatic Encephalopathy
Remove - Pending Acceptance
02/26/2026
SILVER SULFADIAZINE 1%, 25G CREAM (TUBE)
02/26/2026
03/05/2026
TOPICAL
Apply On Affected Area BID
BID
Decubitus Ulcer
Remove - Pending Acceptance
02/26/2026
RIFAXIMIN 200MG (TAB)
02/26/2026
03/05/2026
PO
2 Tabs
TID
Hepatic Encephalopathy
Remove - Pending Acceptance

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: